ID Consult

Young children with neuromuscular disease are vulnerable to respiratory viruses

Publish date: May 15, 2019

 

References

1. Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002297.

2. “Advances in RSV Vaccine Research and Development – A Global Agenda.”

3. J Pediatric Infect Dis Soc. 2015 Dec;4(4): e143-6.

4. J Virol. 2015 Oct;89(20):10319-32.

5. Vaccine. 2017 Dec 18;35(51):7139-46.

Pages

Recommended Reading

PCV13 vaccine reduces frequency of otitis media visits
MDedge Pediatrics
Rotavirus vaccine had strong protective effect in routine U.K. practice
MDedge Pediatrics
No exudates or fever? Age over 11? Skip strep test
MDedge Pediatrics
N.Y. hospitals report near-universal CMV screening when newborns fail hearing tests
MDedge Pediatrics
U.S. measles cases climb to over 800 for the year
MDedge Pediatrics
Flu vaccine visits reveal missed opportunities for HPV vaccination
MDedge Pediatrics
Infections within first year of life predicted IBD
MDedge Pediatrics
Is it measles? – Diagnosis and management for the pediatric provider
MDedge Pediatrics
Maternal immunization protects against serious RSV infection in infancy
MDedge Pediatrics
Measles complications in the U.S. unchanged in posteradication era
MDedge Pediatrics